Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.04 USD | +0.37% | +9.09% | -28.53% |
09/05 | Transcript : Altimmune, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Earnings Flash (ALT) ALTIMMUNE Reports Q1 Revenue $5,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.53% | 57Cr | |
+9.58% | 11TCr | |
+12.41% | 11TCr | |
-2.59% | 2.2TCr | |
-12.38% | 2.19TCr | |
-5.29% | 1.92TCr | |
-3.35% | 1.81TCr | |
-38.57% | 1.77TCr | |
+7.51% | 1.43TCr | |
+35.67% | 1.24TCr |
- Stock Market
- Equities
- ALT Stock
- News Altimmune, Inc.
- B. Riley Securities Raises Altimmune's Price Target to $26 from $21, Increases Likelihood of Technical, Regulatory Success; Keeps Buy Rating